Thiazide Diuretics and Fracture Risk: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

BONE MINERAL DENSITY DIURETICS  FRACTURE SYSTEMATIC REVIEW THIAZIDE

Journal

JBMR plus
ISSN: 2473-4039
Titre abrégé: JBMR Plus
Pays: England
ID NLM: 101707013

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 05 05 2022
revised: 31 08 2022
accepted: 05 09 2022
entrez: 18 11 2022
pubmed: 19 11 2022
medline: 19 11 2022
Statut: epublish

Résumé

Thiazide diuretics are commonly used antihypertensive agents. Until today, whether their use reduces fracture risk remains unclear. Our objective was to conduct a systematic review of thiazide diuretics' effects on fractures and bone mineral density (BMD) in randomized clinical trials (RCT) of adults. MEDLINE, EMBASE, CENTRAL, and the WHO's ICTRP registry were searched from inception to July 31, 2019. Two reviewers assessed studies for eligibility criteria: (i) RCTs; (ii) including adults; (iii) comparing thiazides, alone or in combination; (iv) to placebo or another medication; and (v) reporting fractures or BMD. Conference abstracts and studies comparing thiazides to antiresorptive or anabolic bone therapy were excluded. Bias was assessed using Cochrane Collaboration's Risk of Bias Tool-2. The primary outcome was fracture at any anatomical site. Secondary outcomes were osteoporotic fractures, hip fractures, and BMD at femoral neck, lumbar spine, and/or total hip. Fractures were pooled as risk ratios (RRs) using random-effect models. Prespecified subgroup analyses and post hoc sensitivity analyses were conducted. From 15,712 unique records screened, 32 trials (68,273 patients) met eligibility criteria. Thiazides were associated with decreased fractures at any site (RR = 0.87, 95% confidence interval [CI] 0.77-0.98;

Identifiants

pubmed: 36398110
doi: 10.1002/jbm4.10683
pii: JBM410683
pmc: PMC9664541
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e10683

Informations de copyright

© 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Références

Integr Blood Press Control. 2013 Apr 03;6:1-14
pubmed: 23637556
Am J Epidemiol. 1994 Jun 1;139(11):1107-15
pubmed: 8192143
Clin Exp Hypertens. 2000 Jan;22(1):23-32
pubmed: 10685722
Hypertens Res. 2011 Mar;34(3):331-5
pubmed: 21124326
Osteoporos Int. 2001;12(5):417-27
pubmed: 11444092
Clin Pharmacol Ther. 1991 Mar;49(3):322-9
pubmed: 2007326
Osteoporos Int. 2012 Sep;23(9):2381-6
pubmed: 22008882
Am J Hypertens. 2003 Jun;16(6):453-9
pubmed: 12799093
JAMA. 1991 Jan 16;265(3):370-3
pubmed: 1984536
Res Synth Methods. 2016 Mar;7(1):55-79
pubmed: 26332144
Am J Med. 1991 Mar;90(3A):42S-44S
pubmed: 2006659
JAMA. 2003 May 14;289(18):2363-9
pubmed: 12746359
Sci Rep. 2019 Dec 24;9(1):19754
pubmed: 31874989
Eur Heart J. 2013 Jul;34(28):2159-219
pubmed: 23771844
JAMA. 2009 Feb 4;301(5):513-21
pubmed: 19190316
BMJ Open. 2015 Aug 07;5(8):e008086
pubmed: 26253567
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
J Am Soc Nephrol. 2007 Sep;18(9):2509-16
pubmed: 17656470
N Engl J Med. 2001 Feb 1;344(5):333-40
pubmed: 11172164
Am J Hypertens. 1992 Dec;5(12 Pt 1):875-9
pubmed: 1285936
J Cardiovasc Pharmacol. 1990;15 Suppl 4:S95-8
pubmed: 1693740
Int J Clin Pharmacol Res. 1994;14(1):1-9
pubmed: 7927956
Lancet Diabetes Endocrinol. 2016 Feb;4(2):136-47
pubmed: 26489809
JAMA. 2007 Nov 28;298(20):2381-8
pubmed: 18042915
Biometrics. 1994 Dec;50(4):1088-101
pubmed: 7786990
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Osteoporos Int. 1997;7(1):79-84
pubmed: 9102069
Drugs Aging. 2001;18(3):151-64
pubmed: 11302283
Am J Med. 2000 Oct 1;109(5):362-70
pubmed: 11020392
PLoS One. 2011;6(5):e19857
pubmed: 21647425
Am J Physiol Renal Physiol. 2017 Jun 1;312(6):F998-F1015
pubmed: 28274923
Res Synth Methods. 2017 Jun;8(2):181-198
pubmed: 27060925
Kidney Int. 1996 Nov;50(5):1476-82
pubmed: 8914012
Hypertension. 1991 Mar;17(3 Suppl):II2-15
pubmed: 1999373
J Clin Pharmacol. 1995 Jan;35(1):45-51
pubmed: 7751412
Osteoporos Int. 2018 Jul;29(7):1515-1524
pubmed: 29574519
JAMA. 1991 Jun 26;265(24):3255-64
pubmed: 2046107
Osteoporos Int. 2006 Feb;17(2):297-303
pubmed: 16175311
JAMA Intern Med. 2017 Jan 01;177(1):67-76
pubmed: 27893045
JAMA. 2002 Dec 18;288(23):2981-97
pubmed: 12479763
Am J Hypertens. 1996 Apr;9(4 Pt 1):342-60
pubmed: 8722437
Lancet. 1985 Jun 15;1(8442):1349-54
pubmed: 2861311
J Clin Hypertens (Greenwich). 2011 Oct;13(10):722-30
pubmed: 21974759
Am J Cardiol. 1990 May 15;65(18):1265-8
pubmed: 2186606
N Engl J Med. 2016 May 26;374(21):2009-20
pubmed: 27041480
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Osteoporos Int. 2007 Apr;18(4):479-86
pubmed: 17120180
J Hypertens. 2014 Oct;32(10):2054-63; discussiom 2063
pubmed: 24999799
Ann Intern Med. 1993 May 1;118(9):666-73
pubmed: 8489642
Cardiology. 1990;77 Suppl 5:67-74
pubmed: 2279255
Ann Intern Med. 2000 Oct 3;133(7):516-26
pubmed: 11015164
Calcif Tissue Int. 2005 Mar;76(3):167-75
pubmed: 15719207
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Am J Hypertens. 2017 Oct 1;30(10):1008-1014
pubmed: 28531239
Nihon Naibunpi Gakkai Zasshi. 1989 Jun 20;65(6):603-14
pubmed: 2792461
J Hypertens. 2011 Jul;29(7):1448-56
pubmed: 21602713
Hypertens Res. 2015 May;38(5):329-35
pubmed: 25716649
J Hypertens. 2010 Jun;28(6):1141-9
pubmed: 20486273
Hypertens Res. 2009 Feb;32(2):163-7
pubmed: 19262477
J Clin Epidemiol. 1988;41(12):1197-208
pubmed: 2905387
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Age Ageing. 2010 Sep;39(5):609-16
pubmed: 20573778
Hypertens Res. 2009 Sep;32(9):748-52
pubmed: 19590506
J Bone Miner Res. 2007 Mar;22(3):465-75
pubmed: 17144789
J Clin Hypertens (Greenwich). 2010 Dec;12(12):917-26
pubmed: 21122057
N Engl J Med. 2008 May 1;358(18):1887-98
pubmed: 18378519
Diabetes Obes Metab. 2015 Aug;17(8):805-8
pubmed: 25951755
Hypertens Res. 2015 Feb;38(2):132-6
pubmed: 25253582
J Hypertens. 2001 Feb;19(2):343-50
pubmed: 11212979
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
Circ J. 2017 Jun 23;81(7):948-957
pubmed: 28321001
J Clin Hypertens (Greenwich). 2003 Jul-Aug;5(4 Suppl 3):29-35
pubmed: 12941995
JAMA. 2003 May 21;289(19):2534-44
pubmed: 12759325
Osteoporos Int. 2000;11(5):460-6
pubmed: 10912850
Cochrane Database Syst Rev. 2011 Oct 05;(10):CD005185
pubmed: 21975748
Am J Hypertens. 2004 Sep;17(9):793-801
pubmed: 15363822
Ann Intern Med. 2003 Sep 16;139(6):476-82
pubmed: 13679324
JAMA. 1998 Dec 23-30;280(24):2077-82
pubmed: 9875874
Stat Med. 2004 May 15;23(9):1351-75
pubmed: 15116347
NCHS Data Brief. 2015 Nov;(220):1-8
pubmed: 26633197
J Med Libr Assoc. 2006 Jan;94(1):41-7
pubmed: 16404468
JAMA. 1970 Aug 17;213(7):1143-52
pubmed: 4914579
J Hum Hypertens. 1994 Mar;8(3):155-62
pubmed: 8006914
J Intern Med. 2006 Oct;260(4):350-62
pubmed: 16961672
Cochrane Database Syst Rev. 2014 May 29;(5):CD003824
pubmed: 24869750
Res Synth Methods. 2019 Mar;10(1):83-98
pubmed: 30067315
Nat Rev Nephrol. 2011 Sep 27;7(11):669-74
pubmed: 21947122
Clin Ther. 2012 Aug;34(8):1735-50
pubmed: 22784975
PLoS One. 2015 Mar 04;10(3):e0119292
pubmed: 25738503
Trials. 2006 Dec 19;7:33
pubmed: 17177983
Stat Med. 2007 Jan 15;26(1):53-77
pubmed: 16596572
Front Pharmacol. 2019 Nov 21;10:1364
pubmed: 31824314
Osteoporos Int. 2016 Mar;27(3):1181-1189
pubmed: 26449354
N Engl J Med. 2008 Dec 4;359(23):2417-28
pubmed: 19052124
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880
J Bone Miner Res. 2000 May;15(5):894-901
pubmed: 10804019

Auteurs

Louis-Charles Desbiens (LC)

CHU de Québec Research Center L'Hôtel-Dieu de Québec Hospital Quebec Canada.
Department of Medicine, Faculty of Medicine Laval University Quebec Canada.

Nada Khelifi (N)

CHU de Québec Research Center L'Hôtel-Dieu de Québec Hospital Quebec Canada.
Department of Medicine, Faculty of Medicine Laval University Quebec Canada.

Yue-Pei Wang (YP)

CHU de Québec Research Center L'Hôtel-Dieu de Québec Hospital Quebec Canada.
Department of Medicine, Faculty of Medicine Laval University Quebec Canada.

Felix Lavigne (F)

CHU de Québec Research Center L'Hôtel-Dieu de Québec Hospital Quebec Canada.
Department of Medicine, Faculty of Medicine Laval University Quebec Canada.

Véronique Beaulieu (V)

CHU de Québec Research Center L'Hôtel-Dieu de Québec Hospital Quebec Canada.
Department of Medicine, Faculty of Medicine Laval University Quebec Canada.

Aboubacar Sidibé (A)

CHU de Québec Research Center L'Hôtel-Dieu de Québec Hospital Quebec Canada.
Department of Medicine, Faculty of Medicine Laval University Quebec Canada.

Fabrice Mac-Way (F)

CHU de Québec Research Center L'Hôtel-Dieu de Québec Hospital Quebec Canada.
Department of Medicine, Faculty of Medicine Laval University Quebec Canada.

Classifications MeSH